Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W. Dodick, Eric Pearlman, Erin Doty et al.|Cephalalgia|2020Cited by 106
Investigating Psychological Differences Between Nurses and Other Health Care Workers From the Asia-Pacific Region During the Early Phase of COVID-19: Machine Learning ApproachYanhong Dong, Vijay K. Sharma, Matthew Chin Heng Chua et al.|JMIR Nursing|2021Cited by 33
Early onset of effect following galcanezumab treatment in patients with previous preventive medication failuresTodd J. Schwedt, Eric Pearlman, Dulanji Kuruppu et al.|The Journal of Headache and Pain|2021Cited by 28
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled TrialsDulanji Kuruppu, Susan Hutchinson, James North et al.|Advances in Therapy|2021Cited by 17
Analysis of predictive factors in surgical treatment of intractable epilepsy caused by focal cortical dysplasia in childrenJixue Yang, Xiaoli Zhang, Dongming Li et al.|International Journal of Neuroscience|2024Cited by 2